BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 15292694)

  • 1. CT Scan and MRI in the Differentiation of Liver Tumors.
    Hori M; Murakami T; Kim T; Tomoda K; Nakamura H
    Dig Dis; 2004; 22(1):39-55. PubMed ID: 15292694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of biphasic spiral CT and MnDPDP-enhanced MRI in the detection and characterization of liver lesions].
    Grimm J; Müller-Hülsbeck S; Blume J; Biederer J; Heller M
    Rofo; 2001 Mar; 173(3):266-72. PubMed ID: 11293872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
    Hohmann J; Skrok J; Puls R; Albrecht T
    Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The added value of PET/Ce-CT/DW-MRI fusion in assessment of hepatic focal lesions: PET/Ce-CT/DW-MRI fusion in hepatic focal lesion.
    Salem S; Houseni M; Zidan L; Kandil A
    Nucl Med Biol; 2015 Jul; 42(7):637-42. PubMed ID: 25907467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging of the liver.
    Vassiliades VC; Bernardino ME
    Top Magn Reson Imaging; 1990 Jun; 2(3):1-16. PubMed ID: 2161245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differential diagnosis of focal liver lesions using contrast-enhanced MRI with SHU 555 A in comparison with unenhanced MRI and multidetector spiral-CT].
    Jung G; Poll L; Cohnen M; Saleh A; Vogler H; Wettstein M; Willers R; Mödder U; Koch JA
    Rofo; 2005 Nov; 177(11):1571-7. PubMed ID: 16302139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Contrast enhanced ultrasound of the liver--state of the art].
    Dietrich CF; Schreiber-Dietrich D; Schuessler G; Ignee A
    Dtsch Med Wochenschr; 2007 Jun; 132(22):1225-31. PubMed ID: 17520509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
    Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
    Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of benign and malignant focal liver lesions.
    Martin DR; Semelka RC
    Magn Reson Imaging Clin N Am; 2001 Nov; 9(4):785-802, vi-vii. PubMed ID: 11694438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
    Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
    Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is intravenous contrast enhancement effective in improving CT diagnosis of hepatic disease?].
    Ito K; Ono C; Kohno A; Sumi Y; Honda M; Uchimura F; Ogawa K; Ohtaki M
    Nihon Igaku Hoshasen Gakkai Zasshi; 2003 Mar; 63(4):160-70. PubMed ID: 12708059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific imaging characteristic of solitary necrotic nodule of the liver: Marked peripheral rim-like enhancement with internal hypointensity on longer delayed MRI.
    Fang J; Ma X; Yu D; Ma X; Xiang Y; Guo L
    Eur Radiol; 2017 Sep; 27(9):3563-3573. PubMed ID: 28124105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidetector row CT and MR imaging in diagnosing hepatocellular carcinoma.
    Murakami T; Hori M; Kim T; Kawata S; Abe H; Nakamura H
    Intervirology; 2004; 47(3-5):209-26. PubMed ID: 15383731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperenhancing focal liver lesions: differential diagnosis with helical CT.
    Valls C; Andía E; Sanchez A; Gumà A; Serrano T
    AJR Am J Roentgenol; 1999 Sep; 173(3):605-11. PubMed ID: 10470887
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis.
    Reimer P; Jähnke N; Fiebich M; Schima W; Deckers F; Marx C; Holzknecht N; Saini S
    Radiology; 2000 Oct; 217(1):152-8. PubMed ID: 11012438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of combining sequentially acquired gadobenate dimeglumine-enhanced magnetic resonance imaging and resovist-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: comparison with computed tomography hepatic arteriography and computed tomography arterioportography using 16-slice multidetector computed tomography.
    Kim YK; Kwak HS; Han YM; Kim CS
    J Comput Assist Tomogr; 2007; 31(5):702-11. PubMed ID: 17895780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidetector row CT of the liver.
    Oto A; Tamm EP; Szklaruk J
    Radiol Clin North Am; 2005 Sep; 43(5):827-48, vii. PubMed ID: 16098342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristic MR and CT imaging findings of hepatobiliary paragonimiasis and their pathologic correlations.
    Lu CY; Hu YJ; Chen WX
    Acta Radiol; 2012 Jun; 53(5):481-4. PubMed ID: 22661601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Usefulness of superparamagnetic iron oxide particle (AMI-25) enhanced MR imaging for the diagnosis of liver tumors: comparison with contrast enhanced CT].
    Hirohashi S; Hirohashi R; Uchida H; Kachi K; Ohtomo K; Uchiyama G; Niitsu M; Itai Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Jul; 54(8):776-83. PubMed ID: 8072868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
    Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
    Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.